University of Basrah
  • Register
  • Login
  • العربیة

The Medical Journal of Basrah University

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 26, Issue 1
  3. Author

Current Issue

By Issue

By Subject

Keyword Index

Author Index

Indexing Databases XML

About Journal

Aims and Scope

Editorial Board

Advisory Board

Editorial Staff

Facts and Figures

Publication Ethics

Indexing and Abstracting

Related Links

Peer Review Process

News

THE EFFECT OF BROMOCRIPTINE ON C-REACTIVE PROTEIN IN WOMEN WITH HYPERPROLACTINEMIC AMENORRHEA

    Isam Hamo Mahmood

The Medical Journal of Basrah University, 2008, Volume 26, Issue 1, Pages 19-23
10.33762/mjbu.2008.48346

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

ABSTRACT
C-reactive protein has become the subject of avid interest in recent years. Increased concentrations of C-reactive
protein (CRP) became widely accepted as a risk factor of many inflammatory diseases including atherosclerosis,
ischemic vascular diseases, type 2 diabetes mellitus, hypertension and colon cancer. Data evaluating the
concentration of CRP in hyperprolactinemic condition and the effect of bromocriptine on CRP concentration are not
available. Thus the present study was designed to measure the concentration of CRP in a number of women with
hyperprolactinemic amenorrhea and to evaluate the effect of bromocriptine on CRP concentration. The study tackled
sixty women, who had amenorrhea for at least three months and serum prolactin concentration at least twice the
upper limit of normal values. Bromocriptine is administered in a daily dose of 2 (2.5 mg) tablets. Serum prolactin and
serum CRP were assessed before and after bromocriptine administration, using commercial kits. Mean CRP
concentration of the control group was 1.38±1.85 mg/L which is statistically lower than value of 6.35±4.62 mg/L of
the patients before bromocripine therapy (P<0.001). A significant drop of CRP (from a mean of 6.35±4.62 mg/L to a
mean of 2.73±3.14 mg/L) was obtained after treatment with bromocriptine (P<0.001). The correlation between
serum prolactin level and serum CRP level before and after bromocriptine administration was not statistically
significant: r= 0.24, P>0.05 and r = 0.12, P>0.2, respectively. The present study showed that women with
hyperprolactinemic amenorrhea is associated with increased level of CRP and therapy with bromocriptine
significantly reduced CRP, suggesting a possible anti-inflammatory action of bromocriptine in addition to prolactin
lowering effects.
Keywords:
  • PDF
  • XML
(2008). THE EFFECT OF BROMOCRIPTINE ON C-REACTIVE PROTEIN IN WOMEN WITH HYPERPROLACTINEMIC AMENORRHEA. The Medical Journal of Basrah University, 26(1), 19-23. doi: 10.33762/mjbu.2008.48346
Isam Hamo Mahmood. "THE EFFECT OF BROMOCRIPTINE ON C-REACTIVE PROTEIN IN WOMEN WITH HYPERPROLACTINEMIC AMENORRHEA". The Medical Journal of Basrah University, 26, 1, 2008, 19-23. doi: 10.33762/mjbu.2008.48346
(2008). 'THE EFFECT OF BROMOCRIPTINE ON C-REACTIVE PROTEIN IN WOMEN WITH HYPERPROLACTINEMIC AMENORRHEA', The Medical Journal of Basrah University, 26(1), pp. 19-23. doi: 10.33762/mjbu.2008.48346
THE EFFECT OF BROMOCRIPTINE ON C-REACTIVE PROTEIN IN WOMEN WITH HYPERPROLACTINEMIC AMENORRHEA. The Medical Journal of Basrah University, 2008; 26(1): 19-23. doi: 10.33762/mjbu.2008.48346
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 341
  • PDF Download: 162
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

 
This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus